Historique de carrière de Mary Lucus
Anciens postes connus de Mary Lucus
Sociétés | Poste | Début | Fin |
---|---|---|---|
SELECTIS HEALTH, INC. | Comptroller/Controller/Auditor | 01/04/2021 | 05/04/2023 |
Directeur Financier/CFO | 04/03/2022 | 05/04/2023 | |
Secrétaire Général | 31/10/2022 | 05/04/2023 | |
NEUBASE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - | - |
Formation de Mary Lucus
San Diego State University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 4 |
Opérationnelle
Comptroller/Controller/Auditor | 2 |
Director of Finance/CFO | 1 |
Corporate Secretary | 1 |
Sectorielle
Finance | 2 |
Health Technology | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
SELECTIS HEALTH, INC. | Finance |
Entreprise privées | 1 |
---|---|
NeuBase Therapeutics, Inc.
NeuBase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines. The company was founded by Dietrich A. Stephan on March 29, 2002 and is headquartered in Pittsburgh, PA. | Health Technology |
- Bourse
- Insiders
- Mary Lucus
- Expérience